Acta Haematologica
Case Report
Accelerated Phase of Chronic Myeloid Leukemia Presenting with Hypercalcemia and a Mediastinal MassQuitt M.a · Kelner J.b · Sova J.b · Froom P.a · Aghai E.aa Institute of Hematology and b Institute of Pathology, Lady Davis Carmel Hospital, Haifa, Israel
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Published online: May 22, 1998
Issue release date: May 1998
Number of Print Pages: 3
Number of Figures: 1
Number of Tables: 0
ISSN: 0001-5792 (Print)
eISSN: 1421-9662 (Online)
For additional information: https://www.karger.com/AHA
Abstract
A patient with chronic myeloid leukemia developed hypercalcemia as a presenting sign of the accelerated phase of the disease. Ultrasound of the neck showed a large hypodense mass connected to the thyroid gland, which was thought to be a parathyorid tumor and the cause of the hypercalcemia. Histology of the surgically removed mass revealed a chloroma. The patient’s course was complicated by respiratory failure and metastatic calcinosis of the lung, an unusual finding in hypercalcemia of short duration.
Related Articles:
References
-
Oddel WD: Endocrine manifestations of tumors: Ectopic hormone production; in Wyngaarden JB, Smith LH (eds): Cecil Textbook of Medicine. Philadelphia, Saunders, 1985, pp 1077–1080.
- Breslau NA, McGuire JL, Zerwekh JE, Frenkel EP, Pak CYC: Hypercalcemia associated with increased serum calcitriol levels in three patients with lymphoma. Ann Intern Med 1984;100:1–7.
- Walter RM, Greenberg BR: Hypercalcemia in the accelerated phase of chronic myeloid leukemia. Cancer 1980;46:1174–1178.
- Attar E, Prokocimer M, Januszewicz E, Theodor E: Hypercalcemia complicating myelomonoblastic transformation of chronic myeloid leukemia. Acta Haematol 1988;79:211–212.
-
Tricto G, Boogaerts MA, Broeckaert-van Orshoven A, Criel A, Van Hoof A, Van den Berghe H: Hypercalcemia and diffuse osteolytic lesions in the acute phase of chronic myelogenous leukemia. Cancer 1983;52:831–845.
- Kornberg A, Amir G, Leizerowitz R, Rachmilewitz A: Hypercalcemia complicating a megakaryoblastic crisis of chronic myelocytic leukemia. Isr J Med Sci 1988;24:247–249.
-
Colby VT, Carrington LB: Infiltrative lung disease; in Thurlbeck MW (ed): Pathology of Lung. New York, Thieme, 1988, pp 496–498.
-
Dail OH: Metabolic and other diseases; in Dail OH, Hammar SP (eds): Pulmonary Pathology. New York, Springer, 1988, pp 548–551.
- Furukawa Y, Tanaka K, Hasuike T, Hirai M, Misu K, et al: Adult T-cell leukemia lymphoma with metastatic calcification. Rinsho Byori 1991;39:886–890.
- Mundi GR, Ibbotson KJ, D’Souza SM, Simpson EL, Jacobs JW, Martin TJ: The hypercalcemia of cancer. Clinical implications and pathogenic mechanisms. N Engl J Med 1984;310:1718–1727.
- Wysolmerski JJ, Aroadus AE: Hypercalcemia of malignancy: The central role of parathyroid hormone-related protein. Annu Rev Med 1994;45:189–200.
-
Seymour JF, Gagel RF: Calcitriol: The major humoral mediator of hypercalcemia in Hodgkin’s disease and non-Hodgkins disease lymphomas. Blood 1993;82:1384–1394.
- Firkin F, Seymour JF, Watson AM, Grill V, Martin TJ: Parathyroid hormone-related protein in hypercalcemia associated with haematological malignancy. Br J Haematol 1996;94:486–492.
- Sasaki Y, Takahashi T, Tsuyuoka R, Tanaka K, Ishida H, Nakao K, et al: Hypercalcemia mediated by parathyroid hormone-related protein in chronic myeloid leukemia (letter). Am J Hematol 1994;47:251–252.
- Seymour JF, Grill V, Martin TJ, Lee N, Firkin F: Hypercalcemia in the blastic phase of chronic myeloid leukemia associated with elevated parathyroid hormone related protein (letter). Leukemia 1993;7:1672–1675.
-
Ballard HS, Marcus AJ: Hypercalcemia in chronic myelogenous leukemia. N Engl J Med 1970;282:662–665.
-
Joyner MV, Dujardin P, Cassout JP, Andoly P: Hypercalcemia as complication of accelerated chronic granulocytic leukemia. Br Med J 1977;ii:1060.
Article / Publication Details
Published online: May 22, 1998
Issue release date: May 1998
Number of Print Pages: 3
Number of Figures: 1
Number of Tables: 0
ISSN: 0001-5792 (Print)
eISSN: 1421-9662 (Online)
For additional information: https://www.karger.com/AHA
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Get Permission